mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.05 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.09 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |